BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1545316)

  • 1. [Chemosensitivity of head and neck squamous cell carcinomas using subrenal capsule assay--comparative assay of 5-FU, FT, UFT, and HCFU and immunohistochemical study].
    Nakashima T; Miyagi M; Kusumoto T
    Nihon Jibiinkoka Gakkai Kaiho; 1992 Jan; 95(1):95-103. PubMed ID: 1545316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity test for 5-fluorouracil and its analogues, 1-(2-tetrahydrofuryl)-5-fluorouracil, uracil/1-(2-tetrahydrofuryl)-5-fluorouracil (4:1) and 1-hexylcarbamoyl-5-fluorouracil, using the subrenal capsule assay.
    Anai H; Maehara Y; Kusumoto H; Kusumoto T; Sugimachi K
    Oncology; 1988; 45(3):144-7. PubMed ID: 3130595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UFT is more antineoplastic against gastric carcinoma than 5-fluorouracil, 1-(2-tetrahydrofuryl)-5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sugimachi K
    Chemotherapy; 1988; 34(6):484-9. PubMed ID: 3149571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemosensitivity testing for 5-FU and 5-FU derivatives using subrenal capsule assay].
    Anai H; Maehara Y; Kusumoto H; Masuda H; Sugimachi K
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):635-8. PubMed ID: 3103537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human colorectal carcinoma is more sensitive to HCFU than 5-FU and tegafur in in vitro and in vivo drug sensitivity tests].
    Kusumoto T; Maehara Y; Anai H; Kusumoto H; Miyamoto K; Fukuchi K; Sugimachi K
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):257-61. PubMed ID: 3124767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiproliferative effects of fluoropyrimidine derivatives against human tumor xenografts in a subrenal capsule assay.
    Nishiyama M; Takagami S; Kirihara Y; Saeki T; Hirabayashi N; Nosoh Y; Niimoto M; Hattori T
    Jpn J Surg; 1988 Nov; 18(6):725-8. PubMed ID: 2977626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results of the UFT sensitivity test using human urogenital cancers transplanted subcutaneously and under the subrenal capsule of nude mice].
    Murahashi I; Honda M; Mukae K; Hosoya Y; Takasaki E
    Gan To Kagaku Ryoho; 1988 Feb; 15(2):231-5. PubMed ID: 3124766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
    Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sakaguchi Y; Kido Y; Okamura T; Korenaga D; Sugimachi K
    Cancer; 1989 May; 63(9):1693-6. PubMed ID: 2495166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo chemosensitivity test for UFT and FT-207. I--Subrenal capsule assay].
    Nishiyama M; Niimi K; Yamaguchi M; Hirabayashi N; Nosoh Y; Tohge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):109-13. PubMed ID: 3099648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in the treatment of squamous cell carcinoma of the head and neck: the role of UFT.
    Colevas AD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):86-9. PubMed ID: 9348576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT].
    Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Subrenal capsule assay of nude mice for testing the effectiveness of UFT for rat prostatic carcinoma (R3327)].
    Uchida K; Hayashi T; Nishijima Y; Kasaya T; Akaza H; Koiso K; Nemoto R; Harada M
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):229-33. PubMed ID: 8434960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined effects of interferon alpha-A/D with fluoropyrimidine derivatives in the subrenal capsule assay].
    Nishiyama M; Takagami S; Kirihara Y; Saeki T; Niimi K; Kim R; Jinushi K; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8):2285-90. PubMed ID: 3136700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UFT plus carboplatin for head and neck cancer.
    Fujii M; Ohno Y; Tokumaru Y; Imanishi Y; Kanke M; Tomita T; Yamashita T
    Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):72-5. PubMed ID: 11098499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the anticancer drug cocktail "UFT" on metastatic potentials of squamous cell carcinoma (O-1N) in a hamster model.
    Naito Y; Kimura S; Yoshizawa M; Ohtake K; Nakajima T; Saku T
    Oral Oncol; 1998 Sep; 34(5):326-31. PubMed ID: 9861336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2, 4-dihydroxypridine-1 M potassium oxonate (S-1) on head and neck squamous carcinoma cells.
    Nishimura G; Yanoma S; Mizuno H; Satake K; Taguchi T; Ikeda Y; Tsukuda M
    Cancer Lett; 2000 Oct; 159(1):1-7. PubMed ID: 10974399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chemotherapy with fluoropyrimidines for MOPC-104E plasmacytoma transplanted in mice with CCl4 induced chronic liver dysfunction].
    Tsubono M; Nio Y; Imai S; Shiraishi T; Morimoto H; Tseng CC; Tobe T
    Nihon Gan Chiryo Gakkai Shi; 1990 Mar; 25(3):640-7. PubMed ID: 2141051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
    Somekawa Y; Asano K; Taira A; Imai R
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers].
    Nakashima T; Tomita K; Kuratomi Y; Maehara Y; Kohnoe S
    Gan To Kagaku Ryoho; 1990 Jan; 17(1):79-84. PubMed ID: 2297240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.